17 August 2017

Bipolar Disorder Adds to.....


.... Sexual Distress Rate For Women

Share this content:
Women with bipolar disorder have a high prevalence of sexual distress, and their sexual function is closely associated with their mood symptoms and perception of quality of life.Women with bipolar disorder have a high prevalence of sexual distress, and their sexual function is closely associated with their mood symptoms and perception of quality of life.
Women with bipolar disorder have a high prevalence of sexual distress, and their sexual function is closely associated with their mood symptoms and perception of quality of life (QoL), according to a study published in the International Journal of Bipolar Disorders. More

Traumatic Brain Injury .....


.....May Up Later Risk of Dementia

Share this content:
The researchers followed the study participants for about 11 years.The researchers followed the study participants for about 11 years.
HealthDay News — A severe head injury,especially during middle age, could dramatically increase the risk for developing dementia later in life, according to research published online July 5 in PLOS Medicine.
The study included 40,639 Finnish adults between 18 and 65 who had been hospitalized with mild, moderate, or severe traumatic brain injuries (TBIs). The injuries occurred between 1987 and 2014. The researchers followed the study participants for about 11 years. The 20,703 mild TBI patients were hospitalized for less than a day. The 19,936 moderate-to-severe traumatic brain injury patients had been hospitalized for a minimum of three days. More

16 August 2017

E-Scape Bio announces ......

.....extension of funding to develop novel drug for Alzheimer's disease

E-Scape Bio announced an extension of its Series A funding to a total of $63 million. Created as a spin-off from research conducted at the Gladstone Institutes, E-Scape Bio is a biopharmaceutical company with a mission to develop new therapies to treat neurodegenerative disorders such as Alzheimer's disease.
E-Scape Bio obtained an initial investment of $55 million Series A financing from a syndicate of five top-tier venture funds (OrbiMed, Novo Holding A/S, Novartis Venture Fund, Johnson & Johnson Innovation - JJDC, Inc., and Osage University Partners). Its newest investors include Lilly Asia Ventures and Sutter Hill Ventures. More